Upper extremity recovery and functional outcomes in stroke survivors after inpatient rehabilitation

Read full text
Authors: Keng He Kong, Anna Rosiana, Shuen Loong Tham, Audrey Lik Ming Chai, Lay Fong Chin
Cited by: 1
References: 22

Abstract

INTRODUCTION: Upper extremity (UE) impairment is common after stroke. In a cohort of stroke survivors, we sought to evaluate UE impairment before and after rehabilitation, correlate UE impairment with performance of UE-dependent activities of daily living (ADL) and establish the clinical factors associated with UE impairment. METHODS: This is a retrospective review of the data of stroke survivors admitted to a rehabilitation centre in Singapore over a 1-year period. Outcome measures included Fugl-Meyer Assessment of Upper Extremity (FMA-UE) and Functional Independence Measure-ADL (FIM-ADL). Based on the FMA-UE score, upper limb function was classified into 'no to poor', 'limited', 'notable' or 'full' arm-hand capacity. RESULTS: A total of 259 stroke survivors with a mean age of 62.9 ± 12.3 years were studied. Significant improvements were noted in FMA-UE and FIM-ADL scores after rehabilitation (P < 0.01). Of the 135 (52.1%) stroke survivors with no to poor arm-hand capacity, only 32 (23.7%) had good UE outcome, defined as improvement to notable or full arm-hand capacity. Of the stroke survivors with limited arm-hand capacity, 72.2% achieved good UE outcome. Better cognition, less severe stroke and better truncal balance were associated with higher admission FMA-UE scores. CONCLUSION: Significant improvements in UE impairment and related UE-dependent ADL were noted after inpatient rehabilitation. The findings of this study can serve as a guide in educating stroke survivors and caregivers on expected UE outcomes and caregiving needs upon discharge from rehabilitation.

Fields of Study & Subjects

Stroke Rehabilitation and Recovery Botulinum Toxin and Related Neurological Disorders Balance Gait and Falls Prevention

Publication details

Journal / source
Singapore Medical Journal
Publisher
Ovid Technologies (Wolters Kluwer Health)
Publication date
12 January 2026
Language
EN